Publications

Journal Article Research Support, Non-U.S. Gov't Ppublish 1 citation

PubMed: 39748701 DOI: 10.1021/acssynbio.4c00700

Leveraging Engineered Pseudomonas putida Minicells for Bioconversion of Organic Acids into Short-Chain Methyl Ketones.

ACS Synth Biol 14(1):257-272

Authors: Ekaterina Kozaeva, Manuel Nieto-Domínguez, Kent Kang Yong Tang, Maximilian Stammnitz, Pablo Iván Nikel

Affiliations

  • The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, 2800, Denmark.
  • Centre for Genomic Regulation, Barcelona 08003, Spain.

Abstract

Methyl ketones, key building blocks widely used in diverse industrial applications, largely depend on oil-derived chemical methods for their production. Here, we investigated biobased production alternatives for short-chain ketones, adapting the solvent-tolerant soil bacterium Pseudomonas putida as a host for ketone biosynthesis either by whole-cell biocatalysis or using engineered minicells, chromosome-free bacterial vesicles. Organic acids (acetate, propanoate and butanoate) were selected as the main carbon substrate to drive the biosynthesis of acetone, butanone and 2-pentanone. Pathway optimization identified efficient enzyme variants from Clostridium acetobutylicum and Escherichia coli, tested with both constitutive and inducible expression of the cognate genes. By implementing these optimized pathways in P. putida minicells, which can be prepared through a simple three-step purification protocol, the feedstock was converted into the target short-chain methyl ketones. These results highlight the value of combining morphology and pathway engineering of noncanonical bacterial hosts to establish alternative bioprocesses for toxic chemicals that are difficult to produce by conventional approaches.

MeSH

Cells, Biodegradation, Environmental, Ketones, Synthetic Biology, Acetone, Metabolic Engineering

Cited by